🇺🇸 Aspirin + Atorvastatin in United States
59 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 22 April 2025 – 22 April 2026
- Total reports: 59
Most-reported reactions
- Diarrhoea — 8 reports (13.56%)
- Dizziness — 7 reports (11.86%)
- Haemoglobin Decreased — 7 reports (11.86%)
- Hiatus Hernia — 6 reports (10.17%)
- Pyrexia — 6 reports (10.17%)
- Abdominal Pain — 5 reports (8.47%)
- Blood Glucose Increased — 5 reports (8.47%)
- Death — 5 reports (8.47%)
- Dyspnoea — 5 reports (8.47%)
- Haematochezia — 5 reports (8.47%)
Other Cardiovascular approved in United States
Frequently asked questions
Is Aspirin + Atorvastatin approved in United States?
Aspirin + Atorvastatin does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for Aspirin + Atorvastatin in United States?
Fundacion GESICA is the originator. The local marketing authorisation holder may differ — check the official source linked above.